ENHERTU

Breast cancer that is metastatic (has spread to other parts of the body) or cannot be surgically removed is treated with Enhertu.It can only be applied when it has been established that the cancer “overexpresses HER2″—that is, when it overproduces the protein HER2 on the surface of the tumour cells, causing the tumour cells to multiply more quickly.Patients who have had two or more HER2-targeted therapies are treated with Enhertu alone.The active ingredient is trastuzumab deruxtecan.

Enhertu suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

The order for Enhertu will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Only a prescription is required to buy the medication. It needs to be recommended and administered by a medical expert with knowledge of the use of cancer medications. If patients experience severe allergic responses, it should be administered at a location with access to resuscitation equipment.

Enhertu is administered intravenously (by drip) on days 1 and 8 in a repeating three-week cycle. The weight of the patient determines the dose. As long as the course of treatment is still working, it may be continued.

Please contact +91 9818274099 for ENHERTU price in India.

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.